Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $63
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $60 to $63.
June 22, 2023 | 4:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Boston Scientific and raises the price target from $60 to $63.
The raised price target by Citigroup analyst Joanne Wuensch indicates a positive outlook for Boston Scientific's stock in the short term. The Buy rating reaffirms the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100